The share price of Biogen Inc. (NASDAQ:BIIB) tumbled as much as 8 percent, to $395, Friday after sales of the …
12/22 $CS SEES WRITE-DOWN OF ABOUT CHF 2.3B ON TAX REFORM once worked at CSFB i t.. 12/22 BRIEF-Credit Suisse Says it Expects Write-Down Of about Chf 2.3 bln In Q4 201.. 12/22 Credit Suisse : US Tax Cuts and Jobs Act …
The current valuation of Biogen Inc’s (NASDAQ: BIIB) stock represents “a reasonable entry for the Alzheimer's and SMA franchises as well as a couple of other pipeline programs that seem interesting,” Piper Jaffray’s Joshua E. Schimmer …
Key highlights this week include the announcement of a couple of acquisition agreements as well as pipeline news from …
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. Biogen (NASDAQ: BIIB) announced that its Board of Directors authorized a program to repurchase up to $5 billion of the …
Yesterday’s rumored M&A interest in Biogen Inc (NASDAQ:BIIB) spiked the stock 10% in a single day. Now that the euphoria has died down, let’s examine what a realistic takeover number might be. With both Merck and Allergan …
The earnings cycle is sending some mixed signals for the first time this quarter as three more widely watched stocks …